​

Artivion (AORT) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

AORT Stock Forecast

Artivion (AORT) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $33.00, with a high of $33.00 and a low of $33.00. This represents a 43.35% increase from the last price of $23.02.

$15 $19 $23 $27 $31 $35 High: $33 Avg: $33 Low: $33 Last Closed Price: $23.02

AORT Stock Rating

Artivion stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (80.00%), 2 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 2 8 Strong Sell Sell Hold Buy Strong Buy

AORT Price Target Upside V Benchmarks

TypeNameUpside
StockArtivion43.35%
SectorHealthcare Stocks 33.49%
IndustryMedical Device Stocks19.85%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$30.60
Last Closing Price$23.02$23.02$23.02
Upside/Downside--32.93%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2524---6
Mar, 2524---6
Feb, 2524---6
Jan, 2524---6
Dec, 2424---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Daniel StauderJMP Securities$33.00$26.5324.39%43.35%
Aug 09, 2024Suraj KaliaOppenheimer$30.00$25.3318.44%30.32%
Jul 10, 2024Frank TakkinenLake Street$30.00$25.9415.65%30.32%
Jul 02, 2024Frank TakkinenLoop Capital Markets$30.00$26.0215.30%30.32%
May 07, 2024Mike MatsonNeedham$30.00$21.0742.38%30.32%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024Stifel NicolausMarket OutperformMarket Outperformhold
Oct 23, 2024JMP SecuritiesMarket OutperformOutperforminitialise
Oct 23, 2024JMP SecuritiesMarket Outperforminitialise
Sep 27, 2024NeedhamBuyBuyhold
Sep 13, 2024Stifel NicolausBuyBuyhold
Aug 09, 2024OppenheimerOutperformOutperformhold
Jul 02, 2024NeedhamBuyBuyhold
Jul 02, 2024Lake StreetBuyBuyhold
May 07, 2024NeedhamBuyBuyhold
Sep 26, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.44$-0.38$-0.48$-0.75$-0.32--
Avg Forecast$-0.40$0.07$-0.66$-0.74$0.01$0.14$0.40
High Forecast$-0.39$0.07$-0.64$-0.73$0.01$0.14$0.49
Low Forecast$-0.40$0.07$-0.66$-0.75$0.01$0.14$0.27
Surprise %10.00%-642.86%-27.27%1.35%-3300.00%--

Revenue Forecast

$200M $260M $320M $380M $440M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$253.23M$298.84M$313.79M$354.00M$388.54M--
Avg Forecast$251.78M$297.24M$314.34M$349.64M$392.03M$430.23M$477.49M
High Forecast$253.95M$299.81M$317.05M$349.69M$392.13M$433.66M$477.50M
Low Forecast$249.08M$294.06M$310.06M$349.59M$391.93M$426.80M$477.48M
Surprise %0.58%0.54%-0.18%1.25%-0.89%--

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-16.68M$-14.83M$-19.19M$-30.69M$-13.36M--
Avg Forecast$-16.20M$2.72M$-26.73M$-30.57M$338.27K$5.62M$19.52M
High Forecast$-15.97M$2.75M$-26.25M$-29.59M$344.23K$5.71M$19.96M
Low Forecast$-16.38M$2.68M$-27.03M$-30.65M$332.31K$5.52M$11.00M
Surprise %3.00%-646.13%-28.19%0.40%-4049.26%--

AORT Forecast FAQ

Is Artivion stock a buy?

Artivion stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Artivion is a favorable investment for most analysts.

What is Artivion's price target?

Artivion's price target, set by 10 Wall Street analysts, averages $33 over the next 12 months. The price target range spans from $33 at the low end to $33 at the high end, suggesting a potential 43.35% change from the previous closing price of $23.02.

How does Artivion stock forecast compare to its benchmarks?

Artivion's stock forecast shows a 43.35% upside, outperforming the average forecast for the healthcare stocks sector (33.49%) and outperforming the medical device stocks industry (19.85%).

What is the breakdown of analyst ratings for Artivion over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Artivion’s EPS forecast?

Artivion's average annual EPS forecast for its fiscal year ending in December 2025 is $0.14, marking a -143.75% decrease from the reported $-0.32 in 2024. Estimates for the following years are.

What is Artivion’s revenue forecast?

Artivion's average annual revenue forecast for its fiscal year ending in December 2025 is $430.23M, reflecting a 10.73% increase from the reported $388.54M in 2024. The forecast for.

What is Artivion’s net income forecast?

Artivion's net income forecast for the fiscal year ending in December 2025 stands at $5.62M, representing a -142.03% decrease from the reported $-13.359M in 2024. Projections indicate .